FDA approves blood test for colorectal cancer screening among average-risk adults in the US
Headline from KTVZ Bend
By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based biotechnology company Guardant Health, announced Monday that this is t…
KTVZ Bend's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
WASHINGTON — U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths. Test manufacturer Guardant said the Food and Drug Administration approved its Shield test for screening in adults 45 and older…
WASHINGTON (AP) — U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths.
The test works by detecting DNA that cancerous tumors release into the bloodstream and research published in March showed it was 83% effective in finding colorectal cancers.
Guardant Health said its blood test to detect a cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, sending the company's shares up 16% in premarket trading on Monday.
By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based biotechnology company Guardant Health, announced Monday that this is t…
The Food and Drug Administration has approved a blood test intended to detect colorectal cancer, expanding options for screening for the potentially deadly disease.
The first blood test for colorectal cancer was approved Monday by the Food and Drug Administration. Guardant Health's Shield test is for people 45 and older who are at average risk for the disease. The screening method can be completed in a routine doctor's visit – unlike stool tests and colonoscopi…
In a significant advancement for cancer screening, the U.S. Food and Drug Administration has approved a blood test named Shield for detecting colorectal cancer.
(CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.The
WASHINGTON (AP) — U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA approves blood test for colorectal cancer screening among average-risk adults in the US | Since Then
